Syphilis

  • Uploaded by: Mary Joy F. Ching
  • 0
  • 0
  • December 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Syphilis as PDF for free.

More details

  • Words: 1,724
  • Pages: 56
SYPHILIS

Morphology of Treponema pallidum subsp. pallidum

 Causative agent of SYPHILIS  Fine spiral organism with 3 periplasmic    

flagella 10-13 coils Appears white against a dark background Microaerophilic; survives longer in the presence of 3-5% oxygen Composed of phospholoipids bilayer and protein antigens – outer membrane

Scanning Electron Micrograph of T. pallidum

Mode of Transmission  Organism is very fragile, destroyed

rapidly by heat, cold and drying; susceptible to disinfectants  Sexual transmission most common, occurs when abraded skin or mucous membranes come in contact with open lesion.  Can be transmitted to fetus.  Rare transmission from needle stick and blood transfusion.

 Has a remarkable tropism to arterioles

(endarteritis)  2 types of antibodies produced: treponemal and nontreponemal (reagin) 1. Non Treponemal Abs REAGIN – an anti-cardiolipin Ab, reacts with lipid Ags 2. Treponemal Abs – directed against pathogenic T. Pallidum and closely related strains a. Group antibodies – directed against group antigens b. Specific Treponemal Antibodies – specific for each treponemal antigen

 Antigen

1.Wassermann Antigen  Cardiolipin - a normal constituents of host tissue - is a hapten and is bound to the microbial cell in order to be antigenic -a phospholipid  Pathogenic treponemes growing in vivo INCORPORATES this plentiful supply of phospholipid  Microbial cell/ treponemes- is the foreign carrier  Bound phospholipid(cardiolipin)- is the antigenic determinant

2.TREPONEMAL ANTIGEN Reiter CHON (group antigens) - a protein found in most treponemes (both in saprophytic and pathogenic treponemes) Specific Treponemal Antigens - specific for each treponeme species

Clinical Infection

 Syphilis

- French disease/Italian disease/ The Great Pox - also known as the “great imitator” - a disease of blood vessels and of the perivascular areas; can cross the placenta - it is characterized by chancre, fever, sore throat, headache and rash[palms and soles], gummas in skin, neurosyphilis -if untreated, T. Pallidum can

Stages of Disease  Primary  Secondary  Latent  Tertiary  Congenital Syphilis

Primary Syphilis  Organism enters directly through skin

or through mucosal tissue.  Carried by blood throughout the body.  Organisms remaining at the site begin to multiply.

Primary Syphilis Chancre

 Variable incubation period of 10 days to

several months, a primary lesion, chancre, forms at the entrance site.  Chancre begins as a small, usually singular nodule; as it enlarges, the overlying epithelial tissues begins to necrose, resulting in a relatively painless ulcer.  Unlike other bacterial infections, there is no formation of pus unless a secondary bacterial infection sets in.

Primary - Chancre

 Chancre is most frequently seen on the

external genitalia

 In women the lesions may form in the vagina

or on the cervix.  In men it may be inside the urethra, resulting in a serous discharge.

 The lesion heals spontaneously after 1-5

weeks.  Swab of chancre smeared on slide, examined under dark-field microscope, spirochetes will be present.  Thirty percent become serologically positive one week after appearance of chancre, 90% positive after three weeks.

Penis: The most common sites of infection in men are on the penis. Within 90 days of infection (three week average), a painless sore or ulcer called a chancre appears.  This chancre contains a clear fluid that is full of syphiliscausing bacteria making you highly contagious. The chancre will heal even without treatment within a few weeks.

Primary Syphilis - Chancre

Primary Syphilis - Chancre

Fluid From Chancre

Spirochetes in Blood

Secondary Syphilis  Occurs 6-8 weeks after initial chancre,



  

becomes systemic, patient highly infectious. Characterized by localized or diffuse mucocutaneous lesions, often with generalized lymphadenopathy. Primary chancre may still be present. Secondary lesions subside in about 2-6 weeks. Serology tests nearly 100% positive.

Secondary Syphilis  A widespread eruption resembling

psoriasis or pityriasis rosea which prominently involves the hands should always include the differential diagnosis of secondary syphilis.

Secondary Syphilis  Secondary syphilis lesions on back

Around the Mouth: Secondary symptoms can include multiple sores on the penis, anus or around the mouth.  They can also be found in the throat, which cannot be readily seen.

Wart Like Growths: hair loss, white patches on your tongue or multiple wartlike growths called condylomata lata.ike Growths: hair loss, white patches on your tongue or multiple wart-like growths called condylomata lata

Latent Syphilis  Stage of infection in which organisms

persist in the body of the infected person without causing symptoms or signs (asymptomatic).  This stage may last for years.  One-third of untreated latent stage individuals develop signs of tertiary syphilis.  After four years it is rarely communicable sexually but can be passed from mother to fetus.

Tertiary Syphilis  Divided into three manifestations:  Gummatous syphilis  Cardiovascular syphilis  Neurosyphilis

Tertiary Syphilis Gummatous

 Gummas are localized areas of

granulomatous inflammation found on bones, skin and subcutaneous tissue.  Cutaneous gummas may be single or multiple, generally asymmetric and grouped together.  Visceral lesions often cause local destruction of the affected organ.  Contain lymphocytes, plasma cells and perivascular inflammation.

Tertiary Syphilis Buboe of Neck

Tertiary Syphilis

Tertiary Syphilis Gumma

Tertiary Cardiovascular

 This condition appears 20 or more years

post-infection.  Usually involves the aorta.  Invading treponemes cause scarring of the tunica media.  Over many years, the inflammatory scarring weakens the aortic wall, leading to aneurysm formation, which causes incompetence of the aortic valve and narrowing of the coronary ostia.

Tertiary Cardiovascular

 Antibiotic treatment cures the

syphilis infection and stops the progress of cardiovascular syphilis.  The damage that has already occurred may not be reversed.

Neurosyphilis  Caused by invasion of organisms into

the CNS.  Manifests as an insidious but progressive loss of mental and physical functions and is accompanied by mood alterations.  General paresis of the insane:  forgetful,  personality change,  psychiatric symptoms.

 Onset usually 10-20 years after primary

infection.  Treatment may not improve symptoms.

Neurosyphilis  Neurological complications at this stage

include generalized paresis of the insane which results in personality changes, changes in emotional affect, hyperactive reflexes.  Tabes dorsalis, degeneration of lower spinal cord, general paresis and chronic progressive dementia often results in a characteristic shuffling gait.  Can only be diagnosed serologically by VDRL.

Neurosyphilis  Cerebral atrophy, most prominent in

frontal lobes seen in general paresis.

Congenital Syphilis  Transmitted from mother to fetus.  Fetus affected during second or third

trimester.  Forty percent result in syphilitic stillbirth-fetal death that occurs after a 20 week gestation and the mother had untreated or inadequately treated syphilis at delivery.

Congenital Syphilis  According to the CDC, 40% of births

to syphilitic mothers are stillborn.  40-70% of the survivors will be infected, and 12% of these will subsequently die prematurely  Death from congenital syphilis is usually through pulmonary hemorrhage.

Congenital Syphilis  Bone deformities  Blindness  Deafness  Deformed faces  Dental deformities  Skin rashes  Neonatal death

Congenital Syphilis  Live-born infants show no signs

during first few weeks.  Sixty to 90 % develop clear or

hemorrhagic rhinitis.  skin eruptions (rash) especially around mouth, palms of hands and soles of feet.

 Other signs: general

lymphadenopathy, hepatosplenomegaly, jaundice, anemia, painful limbs, and bone abnormalities.

Congenital Syphilis  Early onset syphilis manifests at birth or

months after, exhibiting a diffuse infiltration, scabs and fissuring along the periphery of the mouth, which leave sulci in a radiated pattern or rhagades

Congenital Syphilis  clear or hemorrhagic rhinitis

Congenital Syphilis  Skin eruptions (rash) especially around

mouth, palms of hands and soles of feet

Congenital Syphilis  Hutchinson’s incisors.

SEROLOGIC TESTS FOR SYPHILIS

1.NonTreponemal methods/ Reagin Tests for Syphilis A. VDRL (Venereal Disease Research

Laboratory Test) -uses heated serum (@56ºC for 30min.) as specimen and result is read microscopically PRINCIPLE: FLOCCULATION (agglutination of colloidal particles) Colloidal suspensions of lipoids + REAGIN (+) flocculation

- Rgt Ag: colorless alcoholic solution

containing cardiolipin, lecithin, cholesterol - Rotator: 180rpm for 4 minutes - False (+) VDRL result: SLE, rheumatic fever, IM, malaria, pregnancy Results: no clumping (or slight roughness): nonreactive small clumps: weakly reactive medium or large clumps: reactive

Rapid plasma reagin  -uses unheated serum as specimen 

 



and the result is read microscopically - uses the incorporation cholinechloride to modify the basic VDRL antigen and allows testing of plasma without preliminary heating -Principle: FLOCCULATION -Rgt Ag: colorless alcoholic sol’n containing cardiolifin lecithin cholesterol with charcoal -Rotator: 100 rpm for 8 mins

2. Treponemal Mtds/Specific Mtds

 TPI (T. Pallidum Immobilization Test)

-test of choice for CSF specimen when regain give NR results -Principle: The antibody produced against T. Pallidum plus complement can immobilize the live treponemes. -Rgt ag: live actively motileT.pallidum organisms (extracted from lessions of infected rabbits) -Ab:Patient syphilitic serum -Complement: guinea pig complement -(+) result: immobilization of treponemes (>50% immobile)

(Fluorescent Treponemal Antibody Absorpion Test)  Principle: Indirect Fluorescent    



immunoassay Rgt ag: Dead T.pallidum (Nichols strain) dried and fixed on slide Ab: patient syphilitic serum Absorbent: Reiter treponemes *patient serum is prediluted in a heated culture filtrate of Reiter Treponemes so that grouped antibodies are blocked and the specific antibody will be then free to bind with the Treponemal antigen. Conjugate: Fluorescent-labeled AHG

FTA-ABS Step 1  Teponema pallidum, the known

antigen, is fixed to a microscope slide.

FTA-ABS – Step 2  If there are antibodies against Treponema

pallidum in the patient's serum, they will bind to the spirochete.  All other antibodies are washed from the slide.

FTA-ABS- Step 3

 Fluorescent anti-human gamma globulin (anti-

HGG) is added to the well.  The anti-HGG will bind with human IgG antibodies bound to the Treponema pallidum on the slide.  All unbound anti-HGG is washed from the slide.  Viewed with a fluorescent microscope, the spirochetes will fluoresce

Positive FTA Test for Syphilis Viewed with a Flourescent Microscope

T.Pallidum Hemeagglutination Test

 Principle: Hemeagglutination  Uses RBC coated with treponemal

antigen to detect patients treponemal antibodies  Rgt ag: glutaraldehyde stabilized turkey RBC coated with treponemal antigen  Antibody: patients syphilitic serum  (+) result: hemeagglutination

MHA-TP (Microhemeaggutination T. Pallidum Test)  PRINCIPLE: HEMEAGGLUTINATION  Uses RBC coated wih Treponemal

antigen to detects patients treponemal antibodies  Rgt Ag: tanned formalin sheep RBC coated with treponemal antigen  Ab: Patient’s syphilic serum  Positive result : hemagglutination

Related Documents

Syphilis
December 2019 16
Syphilis
May 2020 6
Syphilis
April 2020 10
Syphilis
December 2019 21
Syphilis
July 2020 12
Tertiary Syphilis
December 2019 23

More Documents from "Lakshya J Basumatary"

Amebiasis
May 2020 14
Syphilis
December 2019 16
Recombinant Dna
May 2020 13
Blood Transfusion
May 2020 13